- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 7/04 - Inactivation or attenuationProducing viral sub-units
Patent holdings for IPC class C12N 7/04
Total number of patents in this class: 1095
10-year publication summary
58
|
61
|
74
|
53
|
65
|
66
|
65
|
43
|
50
|
15
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2837 |
20 |
Intervet International B.V. | 1270 |
15 |
The Regents of the University of California | 19803 |
13 |
Centre National de La Recherche Scientifique | 10311 |
12 |
Xiamen University | 532 |
12 |
Icahn School of Medicine at Mount Sinai | 932 |
11 |
Institut Pasteur | 789 |
11 |
The Research Foundation for The State University of New York | 1602 |
9 |
Cytos Biotechnology AG | 23 |
8 |
Medicago Inc. | 138 |
8 |
Boehringer Ingelheim Vetmedica GmbH | 1263 |
7 |
Massachusetts Institute of Technology | 10002 |
7 |
The Broad Institute, Inc. | 1776 |
7 |
CEVA Sante Animale | 681 |
7 |
Xiamen Innovax Biotech Co., Ltd. | 89 |
7 |
Zoetis Services LLC | 1539 |
7 |
Novartis AG | 10927 |
6 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3361 |
6 |
Iowa State University Research Foundation, Inc. | 763 |
6 |
Pulike Biological Engineering, Inc. | 31 |
6 |
Other owners | 910 |